Inhibition of mTOR signaling by oleanolic acid contributes to its anti‐tumor activity in osteosarcoma cells (Q39605943)

13 September 2017

title

Inhibition of mTOR signaling by oleanolic acid contributes to its anti-tumor activity in osteosarcoma cells (English)

1 reference

13 September 2017

Inhibition of mTOR signaling by oleanolic acid contributes to its anti‐tumor activity in osteosarcoma cells (English)

1 reference

22 November 2024

Rongping Zhou

1 reference

13 September 2017

Zhongmin Zhang

1 reference

13 September 2017

Li Zhao

1 reference

13 September 2017

Chunhong Jia

1 reference

13 September 2017

Song Xu

1 reference

13 September 2017

Qiguang Mai

1 reference

13 September 2017

Ming Lu

1 reference

13 September 2017

Mingjun Huang

1 reference

13 September 2017

Liang Wang

1 reference

13 September 2017

Xiaokai Wang

1 reference

13 September 2017

Dadi Jin

1 reference

13 September 2017

Xiaochun Bai

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21246613

22 November 2024

publication date

18 January 2011

1 reference

full work available at URL

13 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjor.21311

1 reference

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jor.21311

22 November 2024

1 reference

Journal of Orthopaedic Research

22 November 2024

published in

1 reference

13 September 2017

1 reference

13 September 2017

1 reference

13 September 2017

page(s)

846-852

1 reference

Biology and therapeutic advances for pediatric osteosarcoma

13 September 2017

cites work

1 reference

Primary bone osteosarcoma in the pediatric age: state of the art.

21 January 2018

1 reference

Chemoprevention of cancer

21 January 2018

1 reference

Oleanolic acid induces apoptosis in human leukemia cells through caspase activation and poly(ADP-ribose) polymerase cleavage

21 January 2018

1 reference

Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris

21 January 2018

1 reference

Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer.

21 January 2018

1 reference

The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces caspase-dependent and -independent apoptosis in acute myelogenous leukemia

21 January 2018

1 reference

Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR

21 January 2018

1 reference

TOR signaling in growth and metabolism

21 January 2018

1 reference

Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control

21 January 2018

1 reference

Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38.

21 January 2018

1 reference

21 January 2018

mTOR and cancer therapy

1 reference

Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy

21 January 2018

1 reference

Current development of mTOR inhibitors as anticancer agents

21 January 2018

1 reference

Evaluation of the mammalian target of rapamycin pathway and the effect of rapamycin on target expression and cellular proliferation in osteosarcoma cells from dogs.

21 January 2018

1 reference

Critical signaling pathways in bone sarcoma: candidates for therapeutic interventions

21 January 2018

1 reference

Defining the role of mTOR in cancer

21 January 2018

1 reference

Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells

21 January 2018

1 reference

Effects of ursolic acid and oleanolic acid on human colon carcinoma cell line HCT15.

21 January 2018

1 reference

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

21 January 2018

1 reference

Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo

21 January 2018

1 reference

A synthetic triterpenoid, CDDO-Me, inhibits IkappaBalpha kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor kappaB-regulated gene products in human leukemic cells

21 January 2018

1 reference

The novel triterpenoid CDDO-Me suppresses MAPK pathways and promotes p38 activation in acute myeloid leukemia cells

21 January 2018

1 reference

Triterpenoid CDDO-methyl ester inhibits the Janus-activated kinase-1 (JAK1)-->signal transducer and activator of transcription-3 (STAT3) pathway by direct inhibition of JAK1 and STAT3

21 January 2018

1 reference

Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells

21 January 2018

1 reference

Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling

21 January 2018

1 reference

21 January 2018

1 reference

22 November 2024

1 reference

22 November 2024

1 reference

Limb salvage management of pathologic fractures of primary malignant bone tumors

22 November 2024

1 reference

mTOR/p70S6K signal transduction pathway contributes to osteosarcoma progression and patients' prognosis

22 November 2024

1 reference

2-Cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gamma-dependent and -independent pathways

22 November 2024

1 reference

Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling

22 November 2024

1 reference

22 November 2024

Identifiers

DOI

10.1002/JOR.21311

1 reference

release_jclowedc55hrdebaobyc7hnqna

13 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jclowedc55hrdebaobyc7hnqna

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference